Lituanian CDMO Biotechpharma UAB has invested €50m in order to expand its production capacity to 5000 litres.
Up To Date
Latest News
Kiadis Pharma NV has entered a definitive agreement to acquire US-based CytoSen Therapeutics, Inc. in order to...
Researchers at University of Glasgow report that modulation of a specific GPCR results in health benefits...
Chronic inflammatory disease company Immunic Therapeutics starts Nasdaq-trade following merger with Vital...
Scientists from Belgium and the US have found a way to prevent the devasting consequences of herpes...
Evotec SE and Indivumed GmbH have entered into a drug R&D collaboration aimed at developing first-in-class...
Share
